Public Profile

SL BIO

SL BIO, a leading player in the biotechnology sector, is headquartered in South Korea (KR) and operates extensively across Asia and beyond. Founded in 2015, the company has rapidly established itself in the biopharmaceutical industry, focusing on the development and production of innovative cell therapies and regenerative medicine solutions. With a commitment to advancing healthcare, SL BIO offers unique products that leverage cutting-edge technology to enhance patient outcomes. Their core services include the manufacture of advanced therapeutic products, which are distinguished by their high efficacy and safety profiles. Recognised for its significant contributions to the field, SL BIO has achieved notable milestones, positioning itself as a trusted partner in the global biopharmaceutical landscape. The company continues to drive innovation, aiming to transform the future of medicine.

DitchCarbon Score

How does SL BIO's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

0

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

8

Industry Benchmark

SL BIO's score of 0 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.

27%

SL BIO's reported carbon emissions

SL BIO, headquartered in South Korea (KR), currently does not have available carbon emissions data for recent years. As a result, specific figures regarding their Scope 1, 2, or 3 emissions are not provided. However, the company is committed to addressing climate change through various initiatives, although no specific reduction targets or climate pledges have been outlined. In the absence of detailed emissions data, it is essential to monitor SL BIO's future commitments and actions towards sustainability and carbon neutrality within the industry context.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. SL BIO's primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. SL BIO is headquartered in KR, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

SL BIO is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Research Services

Quanticate

GB
Research Services
Updated 11 days ago

FERRING

NL
Research Services
Updated 11 days ago
CDP

ENCISE INC.

JP
Research Services
Updated 11 days ago

Canesta, Inc.

US
Research Services
Updated 3 days ago

Evidera LLC

US
Research Services
Updated 4 days ago

Dfe Pharma

DE
Research Services
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers